EIT PACMAN Study preliminary results: OncoSignal pathway analysis identifies actionable cancer targets.

Volume: 38, Issue: 15_suppl, Pages: e15606 - e15606
Published: May 20, 2020
Abstract
e15606 Background: Precision medicine refers to tailoring of treatment to each individual patient, although identifying tumor driving signaling pathways (SP) that are functionally active is still a challenge. OncoSignal pathway tests quantitatively measure activity of SP such as estrogen receptor (ER), androgen receptor (AR), PI3K, MAPK, Hedgehog (HH), TGF-β, Notch on fresh frozen and formalin-fixed paraffin-embedded (FFPE) tissue samples....
Paper Details
Title
EIT PACMAN Study preliminary results: OncoSignal pathway analysis identifies actionable cancer targets.
Published Date
May 20, 2020
Volume
38
Issue
15_suppl
Pages
e15606 - e15606
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.